Follow-up and surveillance, recurrent modality, and adjuvant treatment strategy in patients with hepatocellular carcinoma (HCC) after curative hepatectomy or local ablation. (IMAGE)

Xia & He Publishing Inc.

Follow-up and surveillance, recurrent modality, and adjuvant treatment strategy in patients with hepatocellular carcinoma (HCC) after curative hepatectomy or local ablation.

Caption

ICI, immune checkpoint inhibitor.

Credit

Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen Li

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted.

License

CC BY-NC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.